Prolonging the time of progesterone supplementation to improve the pregnancy outcomes of single day 6 blastocyst transfer in frozen-thawed cycles: study protocol for a randomized controlled trial

Trials. 2022 Dec 19;23(1):1024. doi: 10.1186/s13063-022-07013-1.

Abstract

Background: Infertility is one of the most important and underappreciated reproductive health problems in developing countries. Currently, in vitro fertilization and embryo transfer is the most effective treatment strategy for infertility. In a frozen-thawed cycle, single-blastocyst transfer can not only ensure relatively higher pregnancy and live birth rates but also effectively reduce the risk of maternal and neonatal complications. In frozen-thawed cycles, progesterone is initiated to promote the final phase of endometrial preparation prior to embryo transfer. However, the optimal duration of exposure to progesterone has remained inconclusive. Therefore, we designed a randomized controlled trial (RCT) to compare the effects of different prolonged progesterone transformation times (P+6 and P+7) on the pregnancy outcomes of D6 single blastocyst transfer in a frozen-thawed cycle.

Methods: This is a single-center, prospective, randomized controlled clinical trial involving 900 patients with single blastocyst transfer in the frozen-thawed cycle, aged from 20 to 38 years, with less than three transfers, and with HRT-cycle single D6 blastocyst transfer in the current cycle. Participants will be randomly assigned (1:1) into two parallel groups: the transfer of day 6 blastocysts on the 7th day of progesterone supplementation and the transfer of day 6 blastocysts on the 6th day of progesterone supplementation. The primary outcome measure is the clinical pregnancy rate. Secondary outcome measures include the miscarriage rate and live birth rate.

Discussion: This is the first randomized controlled trial to compare the transfer of day 6 blastocysts on the 6th and 7th day of progesterone supplementation. The results of this study will provide evidence for whether to prolong the duration of exposure to progesterone prior to embryo transfer.

Trial registration: ClinicalTrials.gov, ID: NCT04938011. Registered on 19 June 2021.

Keywords: Blastocyst; Endometrial preparation; Frozen-thawed embryo transfer; Randomized controlled trial.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Cryopreservation / methods
  • Dietary Supplements
  • Embryo Transfer / methods
  • Female
  • Fertilization in Vitro / methods
  • Humans
  • Infant, Newborn
  • Infertility* / therapy
  • Live Birth
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy Rate
  • Progesterone
  • Randomized Controlled Trials as Topic
  • Retrospective Studies

Substances

  • Progesterone

Associated data

  • ClinicalTrials.gov/NCT04938011